.

Make Better Decisions

  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Citi
Cipla
Colorcon
Covington
AstraZeneca
Novartis
UBS
McKesson
McKinsey

Generated: December 17, 2017

DrugPatentWatch Database Preview

US Patents With Foreign Priority to Denmark Patent: 2004 01006

« Back to Dashboard


Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use
Santarus IncFENOGLIDEfenofibrateTABLET;ORAL022118-001Aug 10, 2007ABRXYesNo► Subscribe► SubscribeYFOR REDUCING TOTAL CHOLESTEROL (TOTAL-C), LDL-C, APO-LIPOPROTEIN B, OR TOTAL TRIGLYCERIDES, AND TREATING HYPERTRIGLYCERIDEMIA
Santarus IncFENOGLIDEfenofibrateTABLET;ORAL022118-002Aug 10, 2007ABRXYesYes► Subscribe► SubscribeYFOR REDUCING TOTAL CHOLESTEROL (TOTAL-C), LDL-C, APO-LIPOPROTEIN B, OR TOTAL TRIGLYCERIDES, AND TREATING HYPERTRIGLYCERIDEMIA
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Table 'thinkbio_newdpw.patent_gazette' doesn't exist